ورود به حساب

نام کاربری گذرواژه

گذرواژه را فراموش کردید؟ کلیک کنید

حساب کاربری ندارید؟ ساخت حساب

ساخت حساب کاربری

نام نام کاربری ایمیل شماره موبایل گذرواژه

برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید


09117307688
09117179751

در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید

دسترسی نامحدود

برای کاربرانی که ثبت نام کرده اند

ضمانت بازگشت وجه

درصورت عدم همخوانی توضیحات با کتاب

پشتیبانی

از ساعت 7 صبح تا 10 شب

دانلود کتاب Hypertension Secrets

دانلود کتاب اسرار فشار خون بالا

Hypertension Secrets

مشخصات کتاب

Hypertension Secrets

ویرایش: 2 
نویسندگان: , ,   
سری:  
ISBN (شابک) : 9780323758529 
ناشر: Elsevier 
سال نشر: 2022 
تعداد صفحات: 244 
زبان: English 
فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) 
حجم فایل: 12 مگابایت 

قیمت کتاب (تومان) : 82,000



ثبت امتیاز به این کتاب

میانگین امتیاز به این کتاب :
       تعداد امتیاز دهندگان : 1


در صورت تبدیل فایل کتاب Hypertension Secrets به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.

توجه داشته باشید کتاب اسرار فشار خون بالا نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.


توضیحاتی درمورد کتاب به خارجی



فهرست مطالب

Cover
IFC
Title Page
Copyright
Dedication
Contributors
Preface
Top 100 Secrets
Chapter 1 - Measurement of Blood Pressure in the Office
	Questions
		1 - What is office blood pressure measurement?
		2 - What are the major types of office BP measurement?
		3 - How should BP measurement be performed in the office?
		4 - What are the sources of error with office BP measurement?
		5 - How is AOBP monitoring performed?
		6 - What is the evidence for office BP as a predictor of cardiovascular outcomes, and how does it compare to out-of-office ...
		7 - What are the thresholds for normal vs. elevated BP values in the office in order to guide treatment?
		8 - What are the treatment threshold and treatment targets for AOBP?
		9 - What is the bottom line with respect to office BP measurement?
	References
Chapter 2 - Ambulatory and Home Blood Pressure Monitoring
	Questions
		1 - What is out-of-office blood pressure monitoring?
		2 - Why is out-of-office BP monitoring performed?
		3 - What is ABPM?
		4 - Why is ABPM performed?
		5 - How is ABPM performed?
		6 - How is ABPM interpreted?
		7 - What is HBPM?
		8 - Why is HBPM performed?
		9 - How is HBPM performed?
		10 - How is HBPM interpreted?
		11 - Are there important differences in the information obtained using ABPM vs. HBPM?
		12 - Does it matter what device is used to perform ABPM and HBPM?
	References
Chapter 3 - Clinical Evaluation of the Patient with Hypertension
	Questions
		1 - What are the objectives of clinical evaluation of a patient with hypertension?
		2 - What is the appropriate method to check blood pressure?
		3 - What are the appropriate requisites when taking blood pressure readings?
		4 - What pertinent information should be obtained during history taking in the patient who initially presents with hyperten...
		5 - What pertinent findings on physical examination should one look for during evaluation of a patient with hypertension?
		6 - What laboratory and diagnostic tests should be performed as part of hypertension evaluation?
		7 - Which patients require additional diagnostic testing?
		8 - What is pseudohypertension?
		9 - What is Osler maneuver?
	Bibliography
Chapter 4 - Hypertensive Emergencies and Urgencies
	Questions
		1 - What is a hypertensive emergency?
		2 - Why do hypertensive emergencies happen?
		3 - What is a hypertensive urgency and how does this differ from a hypertensive emergency?
		4 - What is the pathophysiology of a hypertensive emergency?
		5 - What is the role for the terms “accelerated hypertension”, “malignant hypertension”, and “hypertensive crisis”?
		6 - What are the common etiologies of hypertensive emergencies?
		7 - How do you assess for end-organ damage?
		8 - How do you lower blood pressure safely in a hypertensive emergency?
		9 - How do you lower blood pressure safely in a hypertensive urgency?
		10 - Is it safe to treat a patient with a hypertensive urgency as an outpatient?
		11 - When do I send my patient to the emergency room for high blood pressure?
	Bibliography
Chapter 5 - The Epidemiology of Hypertension
	Questions
		1 - What is the prevalence of hypertension?
		2 - Which groups have a higher risk of developing hypertension and its complications?
		3 - What are the risk factors for hypertension?
		4 - How does hypertension impact health outcomes?
		5 - What percentage of pregnant women are affected by hypertension?
		6 - What is the clinical significance of white coat hypertension?
		7 - How prevalent is masked hypertension?
		8 - What is the impact of resistant hypertension?
		9 - How often do patients have a secondary cause of hypertension?
	Bibliography
Chapter 6 - Physiology of Blood Pressure Regulation
	Questions
		Short-Term Regulation of Blood Pressure
			1 - What are the two components of measured blood pressure and what do they represent?
			2 - What is mean arterial pressure and its hemodynamic determinants?
			3 - What factors determine CO?
			4 - Define the Frank-Starling law of the heart?
			5 - What are the determinants of SVR?
			6 - What are the primary mechanisms involved in the short-term regulation of blood pressure?
			7 - What is the role of the baroreceptor reflex in regulation of MAP?
			8 - What is the role of chemoreceptors in the regulation of blood pressure?
			9 - Describe and indicate the mechanisms involved in the Bezold–Jarisch reflex.
			10 - What are the cardiovascular responses associated with emotion?
			11 - What is the effect of pain on blood pressure?
			12 - Describe the effect of exercise on cardiovascular response?
		Long-Term Regulation of Blood Pressure (Fig. 6.3)
			13 - What are the key factors in the long-term regulation of blood pressure?
			14 - What is pressure natriuresis?
			15 - What is juxtaglomerular apparatus and tubuloglomerular feedback? (Fig. 6.4)
			16 - How does tubuloglomerular feedback increase glomerular filtration rate? (Fig. 6.5)
			17 - How does tubuloglomerular feedback decrease GFR? (Fig. 6.6)
			18 - What is the concept of glomerulotubular balance?
			19 - What are the components of the RAS? (Fig. 6.7)
			20 - How are the plasma levels of renin regulated?
			21 - What are the hemodynamic effects of Ang II and its receptors?
			22. What are the various stimuli for aldosterone release?
			23 - What are the effects of aldosterone and how are they mediated?
			24 - What is the role of the kinin-kallikrein system (KKS) in blood pressure regulation?
			25 - What are endothelins and what role do they play in blood pressure regulation?
			26 - What is the role of prostaglandins in blood pressure regulation? (Fig. 6.8)
			27 - What are the roles of the skin and immune system in blood pressure regulation?
	Bibliography
Chapter 7 - Target Organ Damage or Why Should we Treat Hypertension?
	1 - Which organs are most affected by elevated blood pressure?
	2 - How does hypertension effect target organs?
	3 - What are the effects of hypertension on the heart and vasculature?
	4 - What are the effects of hypertension on the brain?
	5 - What are the effects of hypertension on the kidneys?
	6 - What are the effects of hypertension on the eyes?
	7 - How should patients be evaluated for target organ damage due to hypertension?
	8 - What factors increase the risk of target organ damage due to hypertension?
	9 - What can be done to reduce the risk of target organ damage due to hypertension?
	10 - How should hypertension be managed when target organ damage is already present?
	References
Chapter 8 - Primary Aldosteronism and Mineralocorticoid Hypertension
	Questions
		1 - What is the most common identifiable cause of resistant hypertension?
		2 - What patients should I evaluate for PA?
		3 - How often do patients with PA present without hypokalemia?
		4 - What are the most common causes of PA?
		5 - Why is it important to diagnose PA rather than just treat the hypertension?
		6 - What is the best initial screening test for PA?
		7 - How do antihypertensive medications and other conditions affect the ARR?
		8 - Do I need to withhold interfering medications before checking the ARR?
		9 - What additional testing should be done in a patient with an abnormal ARR?
		10 - How can you accurately differentiate between unilateral and bilateral causes of PA?
		11 - What is the treatment for aldosterone-producing adenoma?
		12 - How is bilateral adrenal aldosterone excess treated?
		13 - What mineralocorticoids other than aldosterone can cause hypertension, and when should this be considered?
	References
Chapter 9 - Glucocorticoid Hypertension
	Questions
		1 - What are glucocorticoids?
		2 - What are mineralocorticoids?
		3 - How do glucocorticoids influence blood pressure?
		Cushing Syndrome
			4 - What is Cushing syndrome?
			5 - Is Cushing syndrome common?
			6 - List the etiologies of Cushing syndrome.
			7 - Describe the clinical manifestations in Cushing syndrome.
			8 - Who should be tested for Cushing syndrome?
			9 - How do we test for Cushing syndrome?
			10 - What is pseudo-Cushing syndrome?
			11 - What are some other caveats of hypercortisolism testing?
			12 - How is the etiology of Cushing Syndrome established?
			13 - What are the treatment options for Cushing syndrome?
		APPARENT MINERALOCORTICOID EXCESS SYNDROME
			14 - What is apparent mineralocorticoid excess syndrome?
			15 - Describe the clinical and laboratory features of AME syndrome.
			16 - How is AME syndrome diagnosed?
			17 - What treatment options are available for patients with AME syndrome?
			18 - Are there nongenetic forms of HSD11B2 dysfunction?
			19 - What are the most common inhibitors of HSD11B2?
	Bibliography
Chapter 10 - Pheochromocytoma and Paraganglioma
	1 - What are pheochromocytoma and paraganglioma?
	2 - What are the differences between pheochromocytoma and paraganglioma?
	3 - What causes pheochromocytoma and paraganglioma?
	4 - What other tumors are associated with hereditary pheochromocytoma-paraganglioma syndromes?
	5 - What are the symptoms and signs of pheochromocytoma and paraganglioma?
	6 - Which patients should be tested for pheochromocytoma and paraganglioma?
	7 - How are pheochromocytoma and paraganglioma diagnosed?
	8 - Can false-positive testing results occur?
	9 - When and how should imaging be used in the evaluation of pheochromocytoma and paraganglioma?
	10 - What is the treatment for pheochromocytoma and paraganglioma?
	11 - What should I do if I think I have diagnosed a pheochromocytoma or paraganglioma?
	References
Chapter 11 - Other Endocrine Causes of Hypertension
	Questions
		1 - How does acromegaly cause hypertension, and when should it be suspected?
		2 - When should testosterone excess be suspected as a cause of hypertension?
		3 - How does PCOS cause androgen excess and hypertension, and how should it be treated?
		4 - Do thyroid disorders cause hypertension?
		5 - Does hyperparathyroidism cause hypertension?
		6 - Does recombinant erythropoietin administration cause hypertension?
		7 - Is there a link between polycythemia and hypertension?
	References
Chapter 12 - Renovascular Hypertension
	Questions
		1 - What is renovascular hypertension?
		2 - What is the prevalence of RVH?
		3 - What are the common and uncommon causes of RVH?
		4 - What is FMD?
		5 - Why does renal artery obstruction cause HTN?
		6 - What clinical signs suggest RVH and may prompt further testing?
		7 - What testing should be performed for evaluation of RVH?
		8 - What increase in creatinine with ACEi/ARB initiation is suggestive of RVH?
		9 - What additional testing is helpful after making a diagnosis of RVH?
		10 - What is the most appropriate initial treatment for RVH?
		11 - What are the indications for revascularization in atherosclerotic RVH?
		12 - When should revascularization be performed with FMD?
		13 - When should surgical revascularization be performed?
	References
Chapter 13 - Drug-Induced Hypertension
	1 - What are the four main mechanisms by which drug-induced hypertension may occur?
	2 - What drug classes cause hypertension by sympathomimetic activation?
	3 - What drug classes cause hypertension by mineralocorticoid activation?
	4 - What drug classes cause hypertension by direct vasoconstriction?
	5 - What drug classes cause hypertension as a withdrawal syndrome?
	6 - What hypertension-producing drugs do patients routinely omit from their medication list?
	7 - Which drugs of abuse cause or worsen hypertension and how?
	8 - How do stimulants cause or worsen hypertension?
	9 - Which antidepressants can cause or worsen hypertension and how?
	10 - Which headache treatments can cause or worsen hypertension and how?
	11 - What commonly used over-the-counter medication can cause or worsen hypertension?
	12 - What supplements can cause or worsen hypertension?
	13 - How does caffeine cause or worsen hypertension?
	14 - What does it mean for a corticosteroid to have glucocorticoid activity or mineralocorticoid activity?
	15 - How do glucocorticoids cause or worsen hypertension?
	16 - How do mineralocorticoids cause or worsen hypertension?
	17 - How do oral contraceptives cause or worsen hypertension?
	18 - How do antifungals cause or worsen hypertension?
	19 - How does licorice cause or worsen hypertension?
	20 - How do NSAIDs cause or worsen hypertension?
	21 - What cancer agents produce hypertension and how?
	22 - What immunosuppressive agents produce hypertension and how?
	23 - Abrupt discontinuation of which recreational drugs may result in hypertension?
	24 - Abrupt discontinuation of which medications may result in hypertension?
	25 - What drug-drug interactions can cause or worsen hypertension?
Chapter 14 - Obstructive Sleep Apnea and Hypertension
	QUESTIONS
		1 - What is obstructive sleep apnea?
		2 - How common is OSA?
		3 - What is the relevance of OSA in HTN?
		4 - What are the humoral and hemodynamic effects of OSA?
		5 - How should patients with suspected OSA in the setting of HTN undergo evaluation?
		6 - What are the treatment modalities for OSA in patients with HTN?
		7 - What are the effects of treatment of OSA on blood pressure in patients with HTN?
		8 - What is the effect of treatment of OSA on blood pressure in patients with resistant HTN?
		9 - What are important aspects of pharmacotherapy of HTN in patients with OSA?
	Bibliography
Chapter 15 - Hereditary Causes Of Hypertension
	QUESTIONS
		1 - How common are hereditary forms of hypertension?
		2 - When should genetic testing be pursued?
		3 - Which hereditary causes of hypertension present in pediatric populations?
		4 - Why do the majority of hereditary causes of hypertension tend toward hypokalemia?
		5 - How does familial hyperkalemic hypertension cause hyperkalemia?
		6 - Which monogenic cause of hypertension is not directly associated with renal salt handling?
		7 - Why is amiloride the ideal treatment for Liddle syndrome?
		8 - What genetic disorders are associated with pheochromocytoma/paraganglioma?
		9 - What secondary cause of hypertension is associated with Turner syndrome?
		10 - What somatic mutations are associated with hypertension?
	References
Chapter 16 - Hypertension in Children and Adolescents
	QUESTIONS
		1 - How is hypertension defined in children and adolescents?
		2 - How common is hypertension in children and adolescents?
		3 - What are the causes of hypertension in children and adolescents?
		4 - What factors contribute to the development of childhood primary hypertension?
		5 - What is the best approach for identifying children and adolescents with high BP?
		6 - How is the diagnosis of hypertension confirmed in children and adolescents?
		7 - How should hypertension in a child or adolescent be evaluated?
		8 - What is the recommended initial treatment for hypertension in children and adolescents?
		9 - When should antihypertensive medications be used in a child or adolescent with hypertension?
		10 - What medications can be used in children with hypertension?
		11 - How should children with hypertension be followed after treatment has been started?
		12 - What about sports participation?
		13 - Are there specific forms of childhood hypertension that require special consideration?
		14 - Does hypertension in childhood have implications for future cardiovascular health?
	Bibliography
Chapter 17 - Hypertension in Chronic Kidney Disease and End-Stage Kidney Disease
	QUESTIONS
		HYPERTENSION IN CHRONIC KIDNEY DISEASE
			1 - What is the prevalence of hypertension in chronic kidney disease?
			2 - How should BP be measured in the office in patients with CKD?
			3 - What is the role of ambulatory blood pressure monitoring and home BP monitoring in CKD?
			4 - What is the pathophysiology of hypertension in CKD?
			5 - What are the consequences of untreated hypertension in patients with CKD?
			6 - What is the target BP in CKD?
			7 - What are some of the nonpharmacologic treatment strategies that can be used in the treatment of hypertension in CKD?
			8 - Why is it important to restrict sodium intake in hypertensive patients with CKD?
			9 - What is the drug of choice for treatment of hypertension in patients with CKD and proteinuria?
			10 - On initiation of treatment with an ACEI/ARB, a rise in serum creatinine is often noted. Why does this occur, and what ...
			11 - Describe the role of diuretics in the treatment of hypertension in CKD.
			12 - What other antihypertensive drugs can be used in patients with CKD?
		HYPERTENSION IN END-STAGE KIDNEY DISEASE
			13 - What is the prevalence of hypertension in end-stage kidney disease?
			14 - What is the optimal timing of measurement of BP in patients on HD?
			15 - How is hypertension defined in patients with ESKD using the different methods of BP measurement?
			16 - What is the pathophysiology of hypertension in ESKD?
			17 - Describe the relationship between BP and the risk for cardiovascular events and death in patients on HD.
			18 - What are the nonpharmacologic interventions to control BP in patients with ESKD?
			19 - Discuss the role of antihypertensive medications in patients with ESKD.
			20 - How do you choose antihypertensive agents in patients with ESKD?
	Bibliography
Chapter 18 - Hypertension in Diabetes
	QUESTIONS
		1 - Is hypertension common in patients with diabetes?
		2 - What are the current guideline-oriented BP goals in patients with hypertension and diabetes?
		3 - What is the main evidence for current BP goals in patients with T2DM?
		4 - What is the evidence for BP goals in patients with T1DM?
		5 - How is hypertension treated in patients with diabetes?
		6 - How does diabetes cause diabetic nephropathy?
		7 - What is the evidence for efficacy of RAAS inhibition in diabetic nephropathy?
		8 - Do all patients with diabetes and chronic kidney disease have diabetic nephropathy?
		9 - How does one manage the side effects of RAAS inhibitors?
		10 - As most patients will require more than one antihypertensive drug, is dual RAAS blockade (ACE inhibitor + ARB) a good ...
		11 - What is the role of SGLT2 inhibitors in treating hypertension in patients with T2DM?
		12 - Should SGLT2 inhibitors be used in hypertensive patients with T2DM with diabetic nephropathy?
		13 - What is the side effect profile of SGLT2 inhibitors?
	Bibliography
Chapter 19 - Hypertension After Transplantation
	Questions
		1 - What is the definition of hypertension in transplant recipients?
		2 - What is the incidence and prevalence of hypertension after transplantation?
		3 - What is the clinical importance of hypertension in kidney transplant recipients?
		4 - What is the pathogenesis of hypertension after kidney transplantation?
		5 - What are the risk factors for hypertension after kidney transplantation?
		6 - How do CNIs affect hypertension after transplantation?
		7 - How do steroids affect hypertension after transplantation?
		8 - How does belatacept affect hypertension after transplantation?
		9 - What is the goal of blood pressure after kidney transplantation?
		10 - What is the significance of low diastolic blood pressure on kidney transplant recipients?
		11 - What approaches should be utilized for treatment of hypertension after kidney transplantation?
		12 - How should calcium channel blockers be utilized in the treatment of hypertension after kidney transplantation?
		13 - How should diuretics be used in the treatment of hypertension after kidney transplantation?
		14 - How should ACEIs and Ang II receptor blockers be used in the treatment of hypertension after kidney transplantation?
		15 - Discuss the role of beta-blockers in the treatment of hypertension after kidney transplantation.
	Bibliography
Chapter 20 - Treatment of Hypertension in Obesity
	Questions
		1 - What is the epidemiology of obesity and hypertension?
		2 - How does obesity cause and/or aggravate hypertension?
		3 - What is the impact of the nonpharmacologic (and nonsurgical) intervention to obesity treatment over hypertension?
		4 - What are the effects of antiobesity drugs in hypertension?
		5 - What BP measurement technique should be used in patients with obesity?
		6 - What are the treatment options for overweight and obesity grade 1?
		7 - Which is the best treatment option when the baseline BMI is greater than 35 kg/m2?
		8 - Does bariatric surgery reduce BP?
		9 - How should hypertension be managed in the perioperative period of a bariatric surgery?
		10 - Is there a better surgical technique for a patient with hypertension?
	References
Chapter 21 - Hypertension in Blacks
	Questions
		1 - What is the prevalence of hypertension in Blacks in the United States?
		2 - Does hypertension have an earlier age of onset in Blacks in comparison to Whites?
		3 - How does the hypertension in Blacks compare with the hypertension in Whites?
		4 - Why is hypertension more prevalent and severe in Blacks compared with Whites?
		5 - What laboratory tests and results are helpful in directing treatment for Black patients?
		6 - Should renin (or renin activity) be measured in all Blacks with hypertension?
		7 - Should aldosterone also be measured?
		8 - Can a different approach to treating hypertension lead to better outcomes for Black patients?
		9 - Spironolactone vs. eplerenone—which one is preferred?
		10 - Why are drugs that reduce ENaC activity so underutilized?
		11 - Amiloride and triamterene are used mostly as potassium-sparing agents in patients. How effective are they as antihyper...
		12 - To what extent are these drugs accepted by patients?
	Bibliography
Chapter 22 - Hypertension in the Elderly
	Questions
		1 - What is the epidemiology of hypertension in the elderly?
		2 - What are some issues of specific importance when evaluating elderly hypertensive patients?
		3 - What is the distribution of hypertensive subtypes in elderly patients?
		4 - What is the major mechanism of ISH in the elderly?
		5 - What is the role of salt sensitivity in the elderly?
		6 - Are there differences in benefit from treatment of hypertension in the elderly compared to younger patients?
		7 - What should the BP treatment targets be for elderly patients?
		8 - How does low DBP affect the treatment decisions in ISH?
		9 - Does frailty modify BP goals?
		10 - Is the approach to antihypertensive drug therapy different for older patients?
		11 - Are there drugs that specifically target ISH?
		12 - What impact does hypertension treatment have on cognition?
		13 - Are there concerns about increased adverse effects from antihypertensive drugs in elderly patients?
	Bibliography
Chapter 23 - Hypertension in Pregnancy
	Questions
		1 - How does pregnancy normally affect blood pressure?
		2 - Describe the classification of hypertension disorders that occur in pregnancy.
		3 - When should secondary causes of hypertension be considered as the cause of hypertension in pregnancy?
		4 - How do you diagnose preeclampsia?
		5 - What is HELLP syndrome?
		6 - What are risk factors for developing preeclampsia?
		7 - What is currently known about the pathogenesis of preeclampsia?
		8 - What can be done to prevent preeclampsia?
		9 - What can be done to treat preeclampsia?
		10 - What are potential complications of preeclampsia?
		11 - What is the target BP in pregnant patients?
		12 - Which antihypertensive agents have acceptable safety profiles to be used in pregnancy?
		13 - Which antihypertensive agents should be avoided in pregnancy?
		14 - What considerations to type of antihypertensive agents should be made in breastfeeding women?
	Bibliography
Chapter 24 - Hypertension in Heart Disease
	Questions
		Treatment of Hypertension in Patients with Coronary Artery Disease and Stable Angina Pectoris
			1 - How does hypertension and its management contribute to coronary artery disease?
			2 - What drugs are recommended for the treatment of hypertension in patients with CAD?
			3 - What are the determinants of coronary artery blood flow, and how would this impact your management of patients with hyp...
			4 - How would consideration of the determinants of CBF impact your management of patients with hypertension and CAD?
			5 - Does the data on low DBP extend to clinical trial data?
			6 - What is the impact of left ventricular hypertrophy on CBF in hypertension?
			7 - Why are patients with aortic regurgitation and accompanied increase in SBP and markedly reduced DBP not experiencing ma...
		Hypertension in Patients with Acute Coronary Syndromes
			8 - What is the impact of hypertension on the prognosis of patients with acute myocardial infarction, and does antihyperten...
		Treatment of Hypertension in Patients with Heart Failure
			9 - What is the main current way to categorize heart failure?
			10 - Which drugs are useful in lowering BP and reducing cardiovascular mortality in patients with hypertension and heart fa...
			11 - What is the target BP for patients with heart failure and hypertension, and what is the evidence for it?
			12 - Does the level of initial BP influence treatment with BP-lowering drugs in HFrEF?
	Bibliography
Chapter 25 - Hypertension in STROKE
	QUESTIONS
		1 - What is the epidemiology of stroke?
		2 - What are the major classifications of stroke and which types are associated with hypertension?
		3 - What are the risk factors for stroke?
		4 - What is the “acute hypertensive response in stroke?”
		5 - How should hypertension be managed in the setting of an acute stroke?
		6 - Does hypertension affect decision making for acute thrombolysis in acute stroke?
		7 - Does hypertension treatment prevent first and recurrent stroke?
		8 - What is the role of hypertension in cerebral aneurysm development and rupture?
		9 - Which antihypertensive agents should be preferred or avoided in intracerebral hemorrhage?
		10 - How should blood pressure be managed differently in the setting of severe intracranial atherosclerosis?
		11 - Which antihypertensive agents should be preferred or avoided in ischemic stroke?
		12 - What is PRES and how should it be treated?
	References
Chapter 26 - Hypertension in the patient with aortic dissection
	Questions
		1 - What are the acute aortic syndromes?
		2 - What are the risk factors for AAS?
		3 - What are typical presenting symptoms for the patient with an acute AoD?
		4 - How should blood pressure be assessed in the patient with an AAS?
		5 - What are unique causes of hypertension in AAS?
		6 - Do all patients with AAS need aggressive treatment of hypertension?
		7 - What medications are recommended for hypertension control in acute AoD?
		8 - What are the goals of hypertension control prior to repair?
		9 - What are the goals of BP management in acute AoD?
		10 - What is the mechanism by which AAS cause complications?
		11 - What happens to the aorta over time in patients with AoD?
		12 - What happens to the aorta over time in patients with IMH and PAU?
		13 - What medications are recommended in patients with AAS in the chronic setting?
		14 - Does hypertension predict dissection recurrence and aneurysm formation?
	References
Chapter 27 - Resistant and pseudoresistant hypertension
	QUESTIONS
		1 - What is the prevalence of resistant hypertension?
		2 - What is the definition of RH?
		3 - What is the definition of pseudo-RH?
		4 - What is the CV risk associated with RH?
		5 - What is the pathophysiology of RH?
		6 - What is the work-up for RH?
		7 - What is the best pharmacologic management of RH?
		8 - What is the role of device therapy for RH?
	Bibliography
Chapter 28 - Hyperkalemia in Hypertension
	Questions
		1 - Why is hyperkalemia important to understand in the management of individuals with ­hypertension?
		2 - How does the body normally manage potassium?
		3 - Define the electrocardiographic changes associated with hyperkalemia.
		4 - How should one approach the hypertensive patient with hyperkalemia?
		5 - What is the role of dietary modification in the prevention of hyperkalemia?
		6 - Define the role of proper diuretic use in mitigation of hyperkalemia.
		7 - How can newer potassium-exchange resins be used in hypertensive individuals with hyperkalemia on RAAS inhibitors?
	References
Chapter 29 - Lifestyle Modifications for Hypertension Management
	Questions
		1 - What is the role of lifestyle modifications in the treatment of hypertension?
		2 - How do you follow a low-sodium diet?
		3 - How do you calculate how much sodium is in foods or beverages?
		4 - How effective is the DASH diet?
		5 - Is the DASH diet more effective with the addition of sodium restriction?
		6 - Can the DASH diet be used in patients with diminished kidney function to lower BP?
		7 - Does the Mediterranean diet result in BP effects?
		8 - Does the Nordic diet result in BP effects?
		9 - Does the Ketogenic diet result in BP effects?
		10 - Does intermittent fasting result in BP effects?
		11 - Does the high potassium diet result in BP effects?
		12 - What are the recommendations for alcohol consumption to reduce BP?
		13 - What effect does heavy alcohol intake have on BP?
		14 - What role does smoking have on BP?
		15 - What is the pathophysiology of obesity-related hypertension?
		16 - What impact does weight loss have in reducing BP?
		17 - What is the role of physical exercise in hypertension?
		18 - How effective is OSA treatment in reducing BP in hypertension?
		19 - What alternative approaches may be beneficial in treating hypertension?
	Bibliography
Chapter 30 - Blood Pressure Treatment Goals
	Questions
		1 - Why is a treatment goal important for hypertension?
		2 - What was the established treatment goal up to 2017, and what was the evidence?
		3 - What new findings contributed to the establishment of new BP treatment goals in 2017?
		4 - What is the new general BP treatment goal for hypertension?
		5 - Is there additional evidence for a goal of less than 130/80 mm Hg since publication of the 2017 ACC/AHA BP guideline?
		6 - What is the current BP treatment goal for adults of 65 years of age or older and why?
		7 - What is the current BP treatment goal for patients with CKD/end-stage kidney disease and why?
		8 - What is the current BP treatment goal for patients with diabetes and why?
		9 - What is the current BP treatment goal for patients who have had a stroke?
		10 - What is the current BP treatment goal for patients with coronary artery disease and heart failure?
		11 - Is there a risk of reducing BP to or below goal in some patients?
		12 - Is there benefit of lowering BP even though the goal may not be met?
		13 - How can I overcome therapeutic inertia?
		14 - What is the best way to monitor the BP goal?
	References
	Bibliography
Chapter 31 - Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blocker
	Questions
		1 - Describe the mechanism of action of antiogensin-converting enzyme inhibitors and angiotensin receptor blockers?
		2 - What differences are seen with regard to the renin-angiotensin-aldosterone system with ACE inhibitors and ARBs? How is ...
		3 - What is the effect of an ACE inhibitor or ARB on glomerular filtration rate?
		4 - In which patient populations is there a proven benefit of using ACE inhibitors or ARBs?
		5 - What is the effect of an ACE inhibitor or ARB on proteinuria?
		6 - What are the potential adverse effects of ACE inhibitors or ARBs?
		7 - In which patient populations should these medications be used with caution?
		8 - Is there any benefit to combined ACE inhibitor and ARB therapy?
	Bibliography
Chapter 32 - Calcium Channel Blockers
	Questions
		1 - How do calcium channel blockers exert their antihypertensive effect?
		2 - Explain the classification system for dihydropyridine-CCBs.
		3 - Nifedipine and amlodipine are often used interchangeably. What are the clinically relevant differences between them?
		4 - Name key trials that support the efficacy and safety of CCBs.
		5 - Can dihydropyridine (e.g., amlodipine) and nondihydropyridine (e.g., diltiazem) be prescribed in combination?
		6 - Are there indications for CCBs apart from hypertension?
		7 - Discuss the potential advantages of CCBs compared to other classes of antihypertensives.
		8 - In which populations should CCBs be prescribed with caution?
		9 - Describe the common adverse effects of CCBs.
		10 - With which commonly prescribed medications do CCBs interact?
	Bibliography
Chapter 33 - Direct vasodilators
	Questions
		Direct smooth muscle arterial vasodilators
			1 - What is a direct smooth muscle arterial vasodilator?
			2 - What is the mechanism of action of direct arterial vasodilators?
			3 - What are the hemodynamic changes associated with direct vasodilators?
			4 - What are the important pharmacokinetic parameters of direct vasodilators?
			5 - What are the side effects of direct vasodilators?
			6 - What monitoring is required for patients taking vasodilators?
			7 - When are direct vasodilators contraindicated?
			8 - What is the level of evidence for using direct smooth muscle arterial vasodilators?
			9 - What is the role of hydralazine in the critical care setting?
			10 - How is hydralazine used in managing hypertension in pregnancy and during lactation?
			11 - What is the benefit of hydralazine in combination with nitrates in the treatment of patients with congestive heart fai...
			12 - What is the role of hydralazine in patients with renal dysfunction?
	Bibliography
Chapter 34 - Loop and thiazide diuretics
	Questions
		1 - What is the mechanism of action of thiazide diuretics?
		2 - What is the mechanism of action of loop diuretics?
		3 - Why are thiazides more effective at reducing blood pressure than loop diuretics?
		4 - What are the most commonly used loop diuretics and how are they dosed?
		5 - What are the most commonly used thiazide diuretics and how are they dosed?
		6 - Do outcomes differ between different thiazide diuretics?
		7 - What are common side effects of loop diuretics?
		8 - What are common side effects of thiazide diuretics?
		9 - Why do thiazide diuretics cause hypercalcemia?
		10 - Why do thiazide diuretics cause hyponatremia more often than loop diuretics?
		11 - Why do diuretics increase the risk of gout?
	REFERENCES
Chapter 35 - Potassium-sparing diuretics
	Questions
		1 - How do potassium-sparing diuretics work?
		2 - Why is this class of diuretics called potassium-sparing diuretics?
		3 - What are the generic names for potassium-sparing diuretics?
		4 - What are common indications for potassium-sparing diuretics?
		5 - How are potassium-sparing diuretics dosed?
		6 - What are the most common side effects and contraindications to the use of potassium-sparing diuretics?
		7 - What drug interactions should be considered before using potassium-sparing diuretics?
	References
Chapter 36 - Alpha antagonists
	Questions
		1 - How do alpha adrenergic receptors contribute to blood pressure regulation?
		2 - Why are quinazoline-derived selective alpha-1 receptor antagonists preferred in modern hypertension management over non...
		3 - Why is doxazosin preferred over other quinazoline-derived alpha antagonists? What are the important pharmacokinetic par...
		4 - How should doxazosin be dosed in typical antihypertensive patients?
		5 - What clinical outcomes can be expected in patients using doxazosin for hypertension control?
		6 - What clinical trial data support the use of alpha antagonists?
		7 - When would alpha antagonists be a preferred treatment option?
		8 - When should alpha antagonists not be used? And what are the side-effects or adverse events to anticipate in patients us...
		9 - Where do alpha antagonists fit in the contemporary management of hypertension?
		10 - Are there any drug interactions with doxazosin?
	References
	Bibliography
Chapter 37 - Beta-blockers
	Questions
		1 - What is the clinical pharmacology of β-adrenergic receptor blockers?
		2 - How are individual β-adrenergic receptor blockers different from each other?
		3 - What are common adverse effects seen with use of β-blockers?
		4 - How has the recommendation for beta-blockers changed with time for hypertension?
		5 - What is the clinical trial evidence for beta-blockers use in hypertension?
		6 - What is the evidence for beta-blockers use for preventing progression of kidney failure?
		7 - What is the evidence for beta-blockers use for management of heart failure in CKD?
		8 - What is the evidence for beta-blockers use in management of hypertension in dialysis?
		9 - What are the practical aspects in the use of beta-blockers for management of hypertension in CKD?
	References
Chapter 38 - Alpha-2 Agonists
	Questions
		1 - How do alpha-2 agonists reduce blood pressure?
		2 - Which medications act primarily as alpha-2 agonists?
		3 - When prescribing an alpha-2 agonist, what are the usual doses?
		4 - What are the most common side effects of alpha-2 agonists?
		5 - What issues can arise when discontinuing alpha-2 agonists?
		6 - How does alpha-2 agonist rebound hypertension (drug withdrawal) present?
		7 - How can alpha-2 agonist rebound hypertension (drug withdrawal) be prevented or treated?
		8 - What conditions, other than hypertension, are treated by use of alpha-2 agonists?
		9 - What commonly used muscle relaxer is primarily an alpha-2 agonist?
		10 - Should an alpha-2 agonist be the preferred agent in specific settings?
		11 - Should these drugs be avoided in certain settings?
	References
Chapter 39 - Drug-Drug and Pharmacogenetic Interactions
	Questions
		1 - What are the possible mechanisms by which medications or supplements affect antihypertensive medication effectiveness?
		2 - What commonly used drugs are associated with drug interactions with antihypertensive medications?
		3 - How does rifampin interact with antihypertensive mediations, and how should you alter treatment?
		4 - Are there any known genetic variants that affect antihypertensive medication effectiveness?
		5 - What genetic variants alter the risk of antihypertensive medication side effects?
		6 - Are there any genetic variants that should be tested for prior to starting an antihypertensive medication?
	References
Chapter 40 - Role of Device Therapy
	Questions
		1 - What do we mean by device therapies in hypertension?
		2 - What is the history of interventions for hypertension?
		3 - How does renal denervation work?
		4 - What is the current evaluation of the effect of renal denervation?
		5 - What are the possible advantages of renal denervation over medications?
		6 - What about long-term efficacy and effect on clinical outcomes?
		7 - What are the potential safety issues or disadvantages of renal denervation?
		8 - Why was there a discrepancy between early studies and later?
		9 - Who should have renal denervation?
		10 - What is the evidence in baroreceptor stimulation or modulation?
		11 - What is the role of a central arteriovenous fistula in controlling hypertension?
		12 - What are the other device therapy options that have been tried?
	References
Chapter 41 - Orthostatic Hypotension
	Questions
		1 - What physiologic responses prevent blood pressure from decreasing acutely when we stand?
		2 - What is orthostatic hypotension?
		3 - How should blood pressure be measured to diagnose OH?
		4 - Describe the most common causes of OH.
		5 - How should a differential diagnosis be established for orthostatic hypotension in a hypertensive patient?
		6 - Which patients are most likely to develop neurogenic OH?
		7 - What are the best clinical assessments for accurately diagnosing neurogenic OH?
		8 - What are the characteristic clinical findings in patients with neurogenic OH?
		9 - What are the physical examination findings commonly observed in patients with neurogenic OH?
		10 - Describe the most commonly used therapeutic agents to treat OH.
		11 - What additional factors must be considered for hospitalized patients?
		12 - How is OH managed in a patient with severe hypertension?
		13 - What are the best pharmacological agents used to treat supine hypertension in the setting of autonomic failure?
	References
Chapter 42 - Baroreflex Dysfunction
	Questions
		1 - What is the baroreflex?
		2 - How does the baroreflex respond to increased blood pressure?
		3 - How does the baroreflex respond to decreased blood pressure?
		4 - What role does the baroreflex play in the long-term control of blood pressure?
		5 - How is baroreflex function assessed?
		6 - What is the Valsalva maneuver?
		7 - What role does the baroreflex play in hypertension?
		8 - How does baroreflex function change with age?
		9 - How does baroreflex function change with obesity?
		10 - Is the role of the baroreflex in hypertension different between men and women?
		11 - What is baroreflex dysfunction?
		12 - What is efferent baroreflex dysfunction (a.k.a. autonomic failure)?
		13 - What is afferent baroreflex dysfunction?
			Etiology
			Presentation
			Management
	References
Chapter 43 - Hypertension – Origins
	Questions
		1 - When did hypertension enter medical nosography as a disease?
		2 - How did the measurement of blood pressure evolve?
		3 - How were the effects of hypertension on organs recognized?
		4 - How did the treatment of hypertension evolve?
	Bibliography




نظرات کاربران